Back
Cinemark Holdings Vs. Keros Therapeutics Industry Stock Comparison
Sell
50
CNK
Cinemark Holdings
Last Price:
17.71
Seasonality Move:
-3.44%
Sell
43
KROS
Keros Therapeutics
Last Price:
60.54
Seasonality Move:
-20.18%
Sell
50
Cinemark Holdings (CNK)
is a Sell
Is Cinemark Holdings a Buy, Sell or Hold?
- The current Cinemark Holdings [CNK] share price is $17.72. The Score for CNK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CNK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $60.57. The Score for KROS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNK Stock Price Chart
What is Cinemark Holdings's stock price today?
-
The Cinemark Holdings share price today is $17.72
The current trend is relatively stagnant and CNK is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $60.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.
CNK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 48.6 | Sell |
Chaikin Money Flow: | -2280172 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.51 - 18.73) | Sell |
Bollinger Bands (100): | (14.34 - 18.04) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.33 | Sell |
Relative Strength Index (14 RSI): | 52.59 | Buy |
Chaikin Money Flow: | 191481 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.41 - 62.79) | Buy |
Bollinger Bands (100): | (45.59 - 66.39) | Buy |
CNK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.53 | Buy |
20-day SMA: | 17.95 | Sell |
50-day SMA: | 17.88 | Sell |
200-day SMA: | 16.28 | Buy |
8-day EMA: | 17.61 | Buy |
20-day EMA: | 17.8 | Sell |
50-day EMA: | 17.51 | Buy |
200-day EMA: | 16.29 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.32 | Buy |
20-day SMA: | 58.53 | Buy |
50-day SMA: | 63.26 | Sell |
200-day SMA: | 44.75 | Buy |
8-day EMA: | 57.98 | Buy |
20-day EMA: | 58.88 | Buy |
50-day EMA: | 59.57 | Buy |
200-day EMA: | 50.24 | Buy |
Cinemark Holdings Earnings Growth & CNK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.15 per share, a decrease this year of $0.48 per share, and an increase next year of $0.97 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Cinemark Holdings Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |